Health
Novel neutralizing antibodies targeting SARS-CoV-2 N-terminal domain discovered – News-Medical.Net
A new study by US-based researchers shows the presence of protective antibodies that target the N-terminal domain (NTD) of the spike instead of the spike receptor-binding…
The main thrust of scientific research on therapeutics to counter the ongoing coronavirus disease 2019 (COVID-19) pandemic has been aimed at identifying drugs and antibodies that can act against the entry of the causative virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), into the host cell.
A new study by US-based researchers shows the presence of protective antibodies that target the N-terminal domain (NTD) of the spike instead of the spike receptor-binding domain (RBD).
The…
-
General21 hours agoThousands join pro-Palestinian rallies in towns and cities across Australia amid ceasefire
-
General20 hours agoAustralia’s Diamonds defeat South Africa’s Proteas 65-42 in third netball Test
-
General19 hours agoBathurst 1000 quick hits: Chaz Mostert drinks beer with fans, Erebus owner protests, and drama on Mount Panorama
-
General24 hours agoBeijing blames US for raising trade tensions